Randomized Controlled Trials of Efficacy and Safety With Xeloda as Sequential Adjuvant Therapy After Chemotherapy of Anthracycline and/or Taxane in Breast Cancer of Triple Negative or HER-2 Positive or Axillary Lymph Node Metastasis ≥ 4
Latest Information Update: 06 Jun 2022
At a glance
- Drugs Capecitabine (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 20 Aug 2012 New trial record